DNA damage and repair of head and neck cancer cells after radio- and chemotherapy

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 64, Issue 7-8, 2009, Pages 601-610

  Rusin, Pawel ^a   Walczak, Anna ^a   Zwierzchlejska, Anita ^a   Olszewski, Jurek ^b   Morawiec Bajda, Alina ^b   Kaczmarczyk, Dariusz ^b   Kusmierczyk, Krzysztof ^b   Garncarek, Pawel ^c   Pytel, Dariusz ^b   Sliwinński, Tomasz ^a   Majsterek, Ireneusz ^a,b  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c Regional Hospital in Lodz   (Poland)

Author keywords

Comet assay; DNA damage; Head and neck cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA; HYDROGEN PEROXIDE;

ADULT; ARTICLE; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; FEMALE; GENETICS; HEAD AND NECK TUMOR; HUMAN; KINETICS; MALE; METASTASIS; RADIATION EXPOSURE; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CISPLATIN; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYDROGEN PEROXIDE; KINETICS; MALE; NEOPLASM METASTASIS; RADIOTHERAPY;

EID: 70350610504     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2009-7-821     Document Type: Article

References (30)

1. Caldecott K. W. (2001), Mammalian DNA single-strand break repair: an X-ra(y)ted affair. Bioessays 23, 447-455.
2. Chválová K., Brabec V., and Kašpárková J. (2007), Mechanism of the formation of DNA-protein crosslinks by antitumor cisplatin. Nucleic Acids Res. 35, 1812-1821.
3. D'Souza G., Kreimer A. R., Viscidi R., Pawlita M., Fakhry C., Koch W. M., Westra W. H., and Gillison M. L. (2007), Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356, 1944-1956.
4. Freedman N. D., Abnet C. C., Leitzmann M. F., Hollenbeck A. R., and Schatzkin A. (2007) Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer 110, 1593-1601.
5. Gleich L. L. and Salamone F. N. (2002), Molecular genetics of head and neck cancer. Cancer Control 9, 369-378.
6. Gulston M., de Lara C., Jenner T., Davis E., and O'Neill P. (2004), Processing of clustered DNA damage generates additional double-strand breaks in mam-malian cells post-irradiation. Nucl. Acids Res. 32, 1602-1609.
7. Hoeijmakers J. H. (2001), Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374.
8. Hunt C. R., Sim J. E., Sullivan S. J., Featherstone T., Golden W., Von Kapp-Herr C., Hock R. A., Gomez R. A., Parsian A. J., and Spitz D. R. (1998), Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress. Cancer Res. 58, 3986-3992.
9. Imlay J. A. and Linn S. (1988), DNA damage and oxygen radical toxicity. Science 240, 1302-1309.
10. Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N., Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T., Mizoe J., Tsujii H., and Imai T. (2005), DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers. Mutat. Res. 588, 1-6.
11. Jackson A. L. and Loeb L. A. (2000), Microsatellite instability induced by hydrogen peroxide in Escherichia coli. Mutat. Res. 447, 187-198.
12. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M. J. (2008), Cancer statistics 2008. Cancer J. Clin. 58, 71-96.
13. Kartalou M. and Essigmann J. M. (2001), Mechanisms of resistance to cisplatin. Mutat. Res. 478, 23-43.
14. Khanna K. K. and Jackson S. P. (2001), DNA doublestrand breaks: signaling, repair and the cancer connection. Nat. Genet. 27, 247-254.
15. Klaude M., Eriksson S., Nygren J., and Ahnstrom G. (1996), The comet assay: mechanisms and technical considerations. Mutat. Res. 363, 89-96.
16. Lawrance J. A. L., Mais K. L., and Slevin N. J. (2003), Radiologically inserted gastrostomies: their use in patients with cancer of the upper aerodigestive tract. Clin. Oncol. 15, 87-91.
17. Lindahl T. (2001), Keynote: past, present, and future aspects of base excision repair. Prog. Nucleic Acid Res. Mol. Biol. 68, 17-30.
18. López-Lázaro M. (2007), Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 252, 1-8.
19. Maier H., Dietz A., Gewelke U., Heller W. D., and Weidauer H. (1992), Tobacco and alcohol and the risk of head and neck cancer. Clin. Investig. 70, 320-327.
20. McKenna D. J., Gallus M., McKeown S. R., Downes C. S., and McKelvey-Martin V. J. (2003), Modification of the alkaline comet assay to allow simultaneous evaluation of mitomycin induced DNA cross-link damage and repair of specific DNA sequences in RT4 cells. DNA Repair 2, 879-890.
21. Palyvoda O., Mukalov I., Polanska J., Wygoda A., Drobot L., Widel M., and Rzeszowska-Wolny J. (2002), Radiation-induced DNA damage and its repair in lymphocytes of patients with head and neck cancer and healthy donors. Anticancer Res. 22, 1721-1725.
22. Park S., You X., and Imlay J. A. (2005), Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpx-mutants of Escherichia coli. Proc. Natl. Acad. Sci. USA 102, 9317-9322.
23. Parshad R. and Sanford K. K. (2001), Radiation-induced chromatid breaks and deficient DNA repair in cancer predisposition. Crit. Rev. Oncol. Hematol. 37, 87-96.
24. Saha D. T., Davidson B. J., Wang A., Pollock A. J., Orden R. A., and Goldman R. (2008), Quantification of DNA repair capacity in whole blood of patients with head and neck cancer and healthy donors by comet assay. Mutat. Res. 650, 55-62.
25. Seeberg E., Eide L., and Bjoras M. (1995), The base excision repair pathway. TIBS 20, 391-397.
26. Singh N. P., McCoy M. T., Tice R. R., and Schneider E. L. (1988), A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191.
27. Sisk E. A., Bradford C. R., Carey T. E., Paulino A., and Robertson E. (2003), Epstein-Barr virus detected in a head and neck squamous cell carcinoma cell line derived from an immunocompromised patient. Arch. Otolaryngol. Head Neck Surg. 129, 1115-1124.
28. Sotiriou C., Lothaire P., Dequanter D., Cardoso F., and Awada A. (2004), Molecular profiling of head and neck tumors. Head Neck 3, 211-214.
29. Weijl N. I., Hopman G. D., Wipkink-Bakker A., Lentjes E. G., Berger H. M., Cleton F. J., and Osanto S. (1998), Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann. Oncol. 9, 1331-1337.
30. Zhou S., Kachhap S., Sun W., Wu G., Chuang A., Poeta L., Grumbine L., Mithani S. K., Chatterjee A., Koch W., Westra W. H., Maitra A., Glazer C., Carducci M., Sidransky D., McFate T., Verma A., and Califano J. A. (2007), Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc. Natl. Acad. Sci. USA 104, 7540-7545.